Delivering unique monoclonal antibodies of extreme specificity
SYnAbs' mission is to generate innovative antibodies against poor immunogenic compounds and complex antigens.
Either as a custom service,
or as a catalog product,
you can benefit
from SYnAbs technologies
to get access to
unique monoclonal antibodies.
In SYnAbs they trust
The benefits of SYnAbs technologies?
- Extreme specificity monoclonal antibodies
- Higher affinity monoclonal antibodies
- Excellent results for small, difficult and poor immunogenic antigens
- Additional epitope recognition
- High and stable producer clones
- Access to multiple immune repertoires
- Raising antibodies against difficult to express antigens
- Generating antibodies against conformation sensitive targets
SYnAbs 2020 agenda
Feb 3rd- Feb 6th
Feb 4th - Feb 5th
Feb 5th - Feb 6th
March 26th - March 27th
May 28th
June 8th - June 11th
June 10th - June 11th
July 26th - July 30th
Nov 11th - Nov 13th
Nov 16th - Nov 19th
Dec 10th
Dubai, Emirates, Medlab
Evreux, France, Polepharma Biotesting Day
Strasbourg, France, Bioproduction Buzz4Bio
Ghent, Belgium, Translational Immunology
Ghent, Belgium, Knowledge for Growth
San Diego, USA, BIO International Convention
Oxford, United Kingdom, Pivotal Scientific
Chicago, USA, AACC
Oxford, United Kingdom, HAH
Dusseldorf, Germany, MEDICA
Louvain-la-Neuve, Belgium, BioWin Day